ENDLOS-TURBO PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 04:04:42 2024-06-07 am EDT | ||
| 9.49 EUR | +0.85% |
|
| Current month | -8.02% | ||
| 1 month | -11.39% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 9.49 | +0.85% |
| 24-06-06 | 9.41 | +4.09% |
| 24-06-05 | 9.04 | -3.21% |
| 24-06-04 | 9.34 | -3.01% |
| 24-06-03 | 9.63 | -5.87% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 04:04 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DW7X6S |
| ISIN | DE000DW7X6S7 |
| Date issued | 2022-11-24 |
| Strike | 332.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.95 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.61 € |
|---|---|
| Lowest since issue | 0.73 € |
| Spread | 0.09 € |
| Spread % | 0.94% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
232
USD
Average target price
284.6
USD
Spread / Average Target
+22.70%
- Stock Market
- Certificates
- Certificat
